1-8 of 8
Xiaolian Wen
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Orelabrutinib plus rituximab-based chemoimmunotherapy regimens in relapsed or refractory marginal zone lymphoma: A multicentric phase II trial

Free
Shaohua Wu, Li Ma, Jingrong Wang, Xiaolian Wen, Meijing Zheng, Bing Xu, Hongling Ma, Yanli Wang, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 7117.
https://doi.org/10.1182/blood-2025-7117
Published: 2025
Journal Articles

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with azacitidine and  Chidamide can be an effective chemotherapy regimen for patients with angioimmunoblastic T-cell lymphoma (AITL)

Free
Yanli Wang, Xuliang Shen, Guoxiang Zhang, Li Liang, Li Ma, Bing Xu, Jingrong Wang, Shaohua Wu, Min Bai, Xiaolian Wen, Le Li, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 3652.
https://doi.org/10.1182/blood-2025-3652
Published: 2025
Journal Articles

Rituximab, cyclophosphamide, mitoxantrone hydrochloride liposome, vincristine, and prednisone (R-CMOP) in elderly patients with newly diagnosed diffuse large B-cell lymphoma: A multicenter, prospective study

Free
Xiaolian Wen, Lieyang Wang, Li Ma, Bing Xu, Yanping Ma, Jingrong Wang, Shaohua Wu, Jin Zhao, Zhiqiang Zhao, Yalan Wang, Jie Liu, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 3697.
https://doi.org/10.1182/blood-2025-3697
Published: 2025
Journal Articles

Mitoxantrone hydrochloride liposome (Lipo-MIT) combined with rituximab, gemcitabine, dexamethasone, and cisplatin (R-GDPM) in Relapsed/Refractory diffuse large B-cell lymphoma: A multicenter, single-arm study

Free
Li Ma, Jin Zhao, Jingrong Wang, Bing Xu, Meijing Zheng, Junyuan Lang, Xiaolian Wen, Bin Yang, Shaohua Wu, Yanli Wang, Li Liang, Liping Su
Journal: Blood
Blood (2025) 146 (Supplement 1): 5476.
https://doi.org/10.1182/blood-2025-5476
Published: 2025
Journal Articles

Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with Azacitidine and Chidamide Can be an Effective Chemotherapy Regimen for Patients with Angioimmunoblastic T-Cell Lymphoma (AITL)

Free
Yanli Wang, Li Lang, Li Ma, Jingrong Wang, Shaohua Wu, Min Bai, Xuliang Shen, Xiaolian Wen, Le Li, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6514.
https://doi.org/10.1182/blood-2024-205043
Published: 2024
Journal Articles

Mitoxantrone Hydrochloride Liposome (Lipo-MIT) Combined with R-GDP Regimen in Relapsed/Refractory Diffuse Large B-Cell Lymphoma: A Multicenter, Single-Arm Study

Free
Li Ma, Jin Zhao, Jingrong Wang, Meijing Zheng, Xiaolian Wen, Junyuan Lang, Bin Yang, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6506.
https://doi.org/10.1182/blood-2024-205306
Published: 2024
Journal Articles

R-Cmop in Elderly Patients with Newly Diagnosed Diffuse Large B-Cell Lymphoma: A Multicenter, Prospective Study

Free
Xiaolian Wen, Lieyang Wang, Li Ma, Jingrong Wang, Shaohua Wu, Zhiqiang Zhao, Yalan Wang, Liping Su
Journal: Blood
Blood (2024) 144 (Supplement 1): 6487.
https://doi.org/10.1182/blood-2024-207588
Published: 2024
Journal Articles

Circulating Tumour DNA Measurements As an Early Prognostic Indicator for Newly Diagnosed Diffuse Large B-Cell Lymphoma Treated with Pola-R-CHP Regimen

Free
Xiaolian Wen, Liping Su, Tao Guan, Jie Liu, Xuliang Shen
Journal: Blood
Blood (2024) 144 (Supplement 1): 6186.
https://doi.org/10.1182/blood-2024-206716
Published: 2024